生物股份
(600201)
| 流通市值：131.44亿 | | | 总市值：131.44亿 |
| 流通股本：11.00亿 | | | 总股本：11.00亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,249,770,267.26 | 756,440,407.6 | 346,463,052.95 | 1,396,413,685.47 |
| 营业收入 | 1,249,770,267.26 | 756,440,407.6 | 346,463,052.95 | 1,396,413,685.47 |
| 二、营业总成本 | 942,963,509.65 | 612,971,608.14 | 269,670,737.42 | 1,278,271,814.19 |
| 营业成本 | 554,044,466.99 | 348,614,661.87 | 161,166,635.21 | 648,887,448.43 |
| 税金及附加 | 26,209,986.41 | 17,624,592.59 | 6,043,048.46 | 23,362,705.58 |
| 销售费用 | 209,438,906.59 | 146,549,592.4 | 53,979,864.03 | 335,424,429.52 |
| 管理费用 | 100,768,428.32 | 74,043,577.8 | 38,810,816.95 | 189,579,715.83 |
| 研发费用 | 83,659,849.88 | 48,365,966.66 | 20,627,231.74 | 131,087,459.56 |
| 财务费用 | -31,158,128.54 | -22,226,783.18 | -10,956,858.97 | -50,069,944.73 |
| 其中:利息费用 | 1,056,759.96 | 26,909.3 | 47,362.31 | 470,251.54 |
| 其中:利息收入 | 32,211,846.45 | 22,415,312.31 | 11,077,915.29 | 51,170,911.87 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -26,559,314.1 | -8,066,590.98 | -1,270,384.44 | -1,982,093.84 |
| 加:投资收益 | -15,802,702.1 | -14,700,590.2 | -449,817.94 | -2,028,932.74 |
| 资产处置收益 | 66,052.4 | 62,755.69 | - | 8,381,813.12 |
| 资产减值损失(新) | -10,632,963.85 | -13,215,448.97 | 3,799,523.02 | -18,598,461.87 |
| 信用减值损失(新) | -27,672,057.74 | -14,244,440.03 | -3,761,264.7 | -50,816,636.88 |
| 其他收益 | 58,226,715.7 | 37,430,251.55 | 22,428,591.19 | 51,673,680.93 |
| 四、营业利润 | 284,432,487.92 | 130,734,736.52 | 97,538,962.66 | 104,771,240 |
| 加:营业外收入 | 390,052.78 | 997,326.58 | 45,803.41 | 377,357.87 |
| 减:营业外支出 | 1,523,140.55 | 1,102,684.56 | 898,559.06 | 528,701.26 |
| 五、利润总额 | 283,299,400.15 | 130,629,378.54 | 96,686,207.01 | 104,619,896.61 |
| 减:所得税费用 | 43,509,556.41 | 19,200,856.85 | 14,987,666.28 | 9,113,587.29 |
| 六、净利润 | 239,789,843.74 | 111,428,521.69 | 81,698,540.73 | 95,506,309.32 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 239,789,843.74 | 111,428,521.69 | 81,698,540.73 | 95,506,309.32 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 225,919,638.42 | 104,100,301.02 | 80,643,017.03 | 100,111,637.71 |
| 少数股东损益 | 13,870,205.32 | 7,328,220.67 | 1,055,523.7 | -4,605,328.39 |
| 扣除非经常损益后的净利润 | 211,095,248.6 | 89,685,647.91 | 64,486,287.26 | 49,744,333.97 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.21 | 0.1 | 0.07 | 0.09 |
| (二)稀释每股收益 | 0.21 | 0.1 | - | - |
| 八、其他综合收益 | -3,276.34 | -2,284.37 | -1,188.9 | 60,380,493.99 |
| 归属于母公司股东的其他综合收益 | -3,276.34 | -2,284.37 | -1,188.9 | 60,249,293.4 |
| 九、综合收益总额 | 239,786,567.4 | 111,426,237.32 | 81,697,351.83 | 155,886,803.31 |
| 归属于母公司股东的综合收益总额 | 225,916,362.08 | 104,098,016.65 | 80,641,828.13 | 160,360,931.11 |
| 归属于少数股东的综合收益总额 | 13,870,205.32 | 7,328,220.67 | 1,055,523.7 | -4,474,127.8 |
| 公告日期 | 2026-10-31 | 2026-08-04 | 2026-04-23 | 2026-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |